PMC:7696151 / 37621-37914
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1106 | 71-74 | Chemical | denotes | HCQ | MESH:D006886 |
| 1107 | 176-179 | Chemical | denotes | HCQ | MESH:D006886 |
| 1116 | 206-214 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T248 | 0-293 | Sentence | denotes | Food and Drug Administration (FDA) had initially authorized the use of HCQ in case of emergency [61], in June 2020, the FDA revoked this authorization [62] since the potential HCQ effectiveness in treating COVID-19 was overtaken by severe cardiac adverse events and other serious side effects. |